Bio-Techne Corporation (TECH) Stock Overview
Explore Bio-Techne Corporation’s financial performance, market position, analyst ratings, and future outlook.
Bio-Techne Corporation (TECH)
Key Financials
Key Financials
Market Cap
11.3B
P/E Ratio
101.53
EPS (TTM)
$1.94
ROE
0.05%
TECH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Bio-Techne Corporation (NASDAQ: TECH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bio-Techne Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TECH on the NASDAQ shows an RSI of 75.32, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $56.05 for the NASDAQ listing.
Key metrics behind Bio-Techne Corporation's NASDAQ-traded stock include a P/E ratio of 101.53 and a market capitalization of 11.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TECH on the NASDAQ.